Medicare Enrolled

Dr. Mauricio Reinoso, MD PA

Pulmonary Disease · Sugar Land, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
16605 SOUTHWEST FWY, Sugar Land, TX 77479
2819801330
In practice since 2005 (20 years)
NPI: 1972597474 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reinoso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reinoso? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reinoso

Dr. Mauricio Reinoso is a pulmonary disease in Sugar Land, TX, with 20 years in practice. Based on federal Medicare data, Dr. Reinoso performed 2,017 Medicare services across 1,349 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reinoso received a total of $36,408 from 34 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reinoso is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 18% volume in TX$ $36,408 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,017
Medicare services
Top 18% in TX for pulmonary disease
1,349
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~101 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)823$92$225
Hospital follow-up visit, moderate complexity127$62$140
Sleep study including heart rate, breathing, and sleep time121$115$600
Therapy procedure using a positive pressure ventilator114$45$100
New patient office visit (45-59 min)109$146$740
Sleep study in sleep lab with continuous airway pressure (6 years or older)93$134$916
Sleep study in sleep lab (6 years or older)91$128$826
Hospital follow-up visit, high complexity82$93$200
Test to measure expiratory airflow and volume changes before and after medication administration79$29$150
Test to determine lung volumes using sensors77$40$75
Test to examine how well the lungs exchange gases76$42$75
New patient office visit, complex (60-74 min)60$152$390
Initial hospital admission, high complexity58$136$390
Office visit, established patient (20-29 min)37$69$386
Test for exercise-induced lung stress31$25$110
Hospital discharge day management, 30 minutes or less25$63$140
Sleep study including heart rate, breathing, airflow, and effort14$44$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$36,408
Total received (2018-2024)
Avg $5,201/year across 7 years
Top 8% in TX for pulmonary disease
34
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,428 (86.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,980 (13.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$329
2023
$1,329
2022
$783
2021
$448
2020
$6,284
2019
$12,236
2018
$14,999

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sunovion Pharmaceuticals Inc.
$18,337
Mylan Specialty L.P.
$13,079
Inspire Medical Systems, Inc.
$1,332
Veran Medical Technologies, Inc.
$729
AstraZeneca Pharmaceuticals LP
$630
GlaxoSmithKline, LLC.
$421
Actelion Pharmaceuticals US, Inc.
$391
Philips Electronics North America Corporation
$149
Regeneron Healthcare Solutions, Inc.
$138
Gilead Sciences, Inc.
$129
Electromed, Inc.
$105
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Circassia Pharmaceuticals Inc
$81
GENZYME CORPORATION
$80
Olympus America Inc.
$76
Genentech USA, Inc.
$74
Grifols USA, LLC
$67
Takeda Pharmaceuticals U.S.A., Inc.
$51
Eisai Inc.
$43
Insmed, Inc.
$42
United Therapeutics Corporation
$41
Merck Sharp & Dohme LLC
$40
Shionogi Inc
$36
JAZZ PHARMACEUTICALS INC.
$34
Jazz Pharmaceuticals Inc.
$29
Mallinckrodt Hospital Products Inc.
$29
Janssen Pharmaceuticals, Inc
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
Paratek Pharmaceuticals, Inc.
$22
CSL Behring
$18
HARMONY BIOSCIENCES LLC
$17
Xeris Pharmaceuticals, Inc.
$16
Biogen, Inc.
$16
PFIZER INC.
$13
Top 3 companies account for 89.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · 120V · 60Hz · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · Actemra · Adempas · Arikayce · BREO · BREZTRI · DUPIXENT · Dayvigo · Dymista · ELIQUIS · EVUSHELD · Esbriet · FASENRA · Fetroja · GLASSIA · INSPIRE · Inspire Upper Airway Stimulation System · KEVEYIS · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Prolastin-C · Prolastin-C Liquid · SEEBRI · SMARTVEST · SPINRAZA · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · Spin · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON · Utibron · Wakix · XARELTO · XYREM · XYWAV · Xolair · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for pulmonary disease in TX.

Equivalent to $1,805 per 100 Medicare services performed
Looking for a pulmonary disease in Sugar Land?
Compare pulmonary diseases in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
108
Per 100K population
12.6
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reinoso is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), and high industry engagement (speaking/promotional, top 8%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Reinoso experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Reinoso performed 823 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reinoso receive payments from pharmaceutical companies?
Yes. Dr. Reinoso received a total of $36,408 from 34 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reinoso's costs compare to other pulmonary diseases in Sugar Land?
Dr. Reinoso's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reinoso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →